arbiter
JournalsAccount

The Use of Glucagon‐Like Peptide 1 Agonists Among Non‐Diabetics: Evidence From Medicare Part D

Minji Kim et al.

Health Services Research2026https://doi.org/10.1111/1475-6773.70098article
AJG 3ABDC A
Weight
0.50

Abstract

This growth underscores the substantial budgetary implications for Medicare, particularly amid ongoing policy discussions around expanding coverage of GLP-1s for weight management.

Open via your library →

Cite this paper

https://doi.org/https://doi.org/10.1111/1475-6773.70098

Or copy a formatted citation

@article{minji2026,
  title        = {{The Use of Glucagon‐Like Peptide 1 Agonists Among Non‐Diabetics: Evidence From Medicare Part D}},
  author       = {Minji Kim et al.},
  journal      = {Health Services Research},
  year         = {2026},
  doi          = {https://doi.org/https://doi.org/10.1111/1475-6773.70098},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

The Use of Glucagon‐Like Peptide 1 Agonists Among Non‐Diabetics: Evidence From Medicare Part D

Flags are reviewed by the Arbiter methodology team within 5 business days.

Evidence weight

0.50

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.50 × 0.4 = 0.20
M · momentum0.50 × 0.15 = 0.07
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.